Molecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflow

We investigated 15,542 patients with suspected BCR-ABL1- negative myeloproliferative or myelodysplastic/myeloproliferative neoplasm (including 359 chronic myelomonocytic leukemia) by a molecular marker set. JAK2V617F was detected in the suspected categories as follows: polycythemia vera 88.3%, prima...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Schnittger, Susanne, Bacher, Ulrike, Eder, Christiane, Dicker, Frank, Alpermann, Tamara, Grossmann, Vera, Kohlmann, Alexander, Kern, Wolfgang, Haferlach, Claudia, Haferlach, Torsten
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2012
Matèries:
Original Articles and Brief Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3487560/
https://ncbi.nlm.nih.gov/pubmed/22511494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.064683
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars